Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Inhibition of NF-κB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy

Abstract

Virus-directed enzyme prodrug therapy utilizing the bacterial enzyme nitroreductase delivered by a replication-defective adenovirus vector to activate the prodrug CB1954 is a promising strategy currently undergoing clinical trials in patients with a range of cancers. Similarly, selectively replicating oncolytic adenoviruses are entering clinical trials. An understanding of interactions between vector and target cell are critical to the development of these strategies. We demonstrate that adenovirus vectors activate cellular pathways that promote cell survival in an NF-κB-dependent manner, and consequently have a negative effect on the efficacy of cell killing induced by cancer gene therapy strategies. This provides a potential therapeutic target to enhance the cytotoxicity of these approaches.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Palmer DH, Mautner V, Kerr DJ . Clinical experience with adenovirus in cancer therapy. Curr Opin Mol Ther 2002; 4: 423–434.

    CAS  PubMed  Google Scholar 

  2. Khuri FR et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000; 6: 879–885.

    Article  CAS  PubMed  Google Scholar 

  3. Chung-Faye G et al. Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954. Clin Cancer Res 2001; 7: 2662–2668.

    CAS  PubMed  Google Scholar 

  4. Palmer DH et al. Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer. J Clin Oncol 2004; 22: 1546–1552.

    Article  CAS  PubMed  Google Scholar 

  5. Chen MJ et al. Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector. Gene Therapy 2004; 11: 1126–1136.

    Article  CAS  PubMed  Google Scholar 

  6. Melotti P et al. Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed to an adenovirus-derived vector. Gene Therapy 2001; 8: 1436–1442.

    Article  CAS  PubMed  Google Scholar 

  7. Tamanini A et al. MAP kinases and NF-kappaB collaborate to induce ICAM-1 gene expression in the early phase of adenovirus infection. Virology 2003; 307: 228–242.

    Article  CAS  PubMed  Google Scholar 

  8. Clesham GJ et al. High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells. Gene Therapy 1998; 5: 174–180.

    Article  CAS  PubMed  Google Scholar 

  9. Lieber A et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 1997; 71: 8798–8807.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Morelli AE et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol 2000; 74: 9617–9628.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Palmer DH, Milner AE, Kerr DJ, Young LS . Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil. Br J Cancer 2003; 89: 944–950.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Schuurhuis GJ, Oberink JW, Bontje PM, Broxterman HJ . The PGP specific combination Syto® 16/PSC833 detects early apoptosis in CD34 positive progenitor cells. Exp Hematol 1997; 25: 754.

    Google Scholar 

  13. Teramoto S et al. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum Gene Ther 1995; 6: 1045–1053.

    Article  CAS  PubMed  Google Scholar 

  14. Brand K et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Therapy 1999; 6: 1054–1063.

    Article  CAS  PubMed  Google Scholar 

  15. Wersto RP, Rosenthal ER, Seth PK, Eissa NT, Donahue RE . Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J Virol 1998; 72: 9491–9502.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Milner AE et al. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells. Cell Death Differ 2002; 9: 287–300.

    Article  CAS  PubMed  Google Scholar 

  17. Wang CY et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281: 1680–1683.

    Article  CAS  PubMed  Google Scholar 

  18. Lundqvist A et al. Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis. Hum Gene Ther 2002; 13: 1541–1549.

    Article  CAS  PubMed  Google Scholar 

  19. Wang S et al. Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis. Biochem Biophys Res Commun 1999; 259: 67–72.

    Article  CAS  PubMed  Google Scholar 

  20. You Z et al. Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 2001; 276: 26398–26404.

    Article  CAS  PubMed  Google Scholar 

  21. Datta SR et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 31–41.

    Article  Google Scholar 

  22. Datta SR, Brunet A, Greenberg ME . Cellular survival: a play in three Akts. Genes Dev 1999; 13: 2905–2927.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palmer, D., Chen, MJ., Searle, P. et al. Inhibition of NF-κB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy. Gene Ther 12, 1187–1197 (2005). https://doi.org/10.1038/sj.gt.3302510

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302510

Keywords

This article is cited by

Search

Quick links